Sunekos 200 London

The extracellular matrix is composed primarily of collagen, elastin, and glycosaminoglycans. As we age, the ECM degrades — leading to fine lines, wrinkles, skin laxity, and loss of volume. Sunekos works at a cellular level, stimulating fibroblasts to produce new collagen and elastin, effectively rebuilding the skin's foundation.

Developed by Italian pharmaceutical company Professional Derma, Sunekos holds a patent for its specific amino acid formulation. The six amino acids (glycine, L-proline, L-leucine, L-lysine, L-valine, and L-alanine) are combined in precise ratios that have been clinically demonstrated to stimulate ECM regeneration — a mechanism distinct from simple hydration or volume replacement.

At Cosmedocs, we use Sunekos as part of our comprehensive skin rejuvenation portfolio, often recommending it for patients seeking genuine skin quality improvement rather than temporary hydration. Our aesthetics is invisible art — transformation that speaks without saying a word.

The treatment protocol typically involves 3–4 sessions spaced 7–10 days apart. This phased approach allows progressive ECM regeneration, with each session building upon the previous one. Results become increasingly visible as new collagen and elastin fibres mature.

Unlike cross-linked hyaluronic acid fillers that physically occupy space, Sunekos stimulates your own biology to restore skin quality. The non-cross-linked HA component is rapidly integrated into the tissue, providing an optimal environment for the amino acids to exert their regenerative effect.